Cargando…
Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation
Mucoadhesive particles (MAP) have been widely explored for pulmonary drug delivery because of their perceived benefits in improving particle residence in the lungs. However, retention of particles adhesively trapped in airway mucus may be limited by physiologic mucus clearance mechanisms. In contras...
Autores principales: | Schneider, Craig S., Xu, Qingguo, Boylan, Nicholas J., Chisholm, Jane, Tang, Benjamin C., Schuster, Benjamin S., Henning, Andreas, Ensign, Laura M., Lee, Ethan, Adstamongkonkul, Pichet, Simons, Brian W., Wang, Sho-Yu S., Gong, Xiaoqun, Yu, Tao, Boyle, Michael P., Suk, Jung Soo, Hanes, Justin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381952/ https://www.ncbi.nlm.nih.gov/pubmed/28435870 http://dx.doi.org/10.1126/sciadv.1601556 |
Ejemplares similares
-
Pretreatment of Human Cervicovaginal Mucus with Pluronic
F127 Enhances Nanoparticle Penetration without Compromising Mucus
Barrier Properties to Herpes Simplex Virus
por: Ensign, Laura M., et al.
Publicado: (2014) -
Altering Mucus Rheology to “Solidify” Human Mucus at the Nanoscale
por: Lai, Samuel K., et al.
Publicado: (2009) -
Effects of inhaled acids on airway mucus and its consequences for health.
por: Holma, B
Publicado: (1989) -
Cervicovaginal mucus barrier properties during pregnancy are impacted by the vaginal microbiome
por: Zierden, Hannah C., et al.
Publicado: (2023) -
The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis
por: Hoang, Thuy, et al.
Publicado: (2020)